ESR1 Mutation Metastatic Breast Cancer Diagnostics Market

Table of Content

1. Introduction
   • Definition of ESR1 Mutated Metastatic Breast Cancer Diagnostics Market
   • Scope of the Report
2. Methodology
   • Executive Summary
   • Market Overview
   • Market Definition and Segmentation
3. Market Dynamics
   • Drivers
   • Restraints
   • Opportunities
   • Porter's Five Forces Analysis
   • PESTEL Analysis
4. ESR1 Mutated Metastatic Breast Cancer Diagnostics Market, Hormonal therapy:
   • Tamoxifen
   • Aromatase inhibitors
   • Ovarian suppression
   • Fulvestrant
   • Elacestrant
5. ESR1 Mutated Metastatic Breast Cancer Diagnostics Market, Chemotherapy:
   • Capecitabine
   • Carboplatin
   • Cisplatin
   • Cyclophosphamide
   • Docetaxel
   • Others
6. ESR1 Mutated Metastatic Breast Cancer Diagnostics Market, Targeted therapy:
   • Monoclonal antibodies
   • Small molecule inhibitors
   • Tumor-agnostic treatments
   • Immunotherapy
   • Pembrolizumab
   • Dostarlimab
7. ESR1 Mutated Metastatic Breast Cancer Diagnostics Market, End User:
   • Hospitals
   • Clinics
   • Research and Academic Institutes
   • Diagnostic Centres
8. ESR1 Mutated Metastatic Breast Cancer Diagnostics Market, By Geography
   • North America
     • United States
     • Canada
   • Europe
     • United Kingdom
     • Germany
     • France
     • Spain
     • Italy
     • Rest of Europe
   • Asia-Pacific
     • China
     • Japan
     • India
     • South Korea
     • Australia
     • Rest of Asia-Pacific
   • Latin America
     • Brazil
     • Mexico
     • Rest of Latin America
   • Middle East & Africa
     • Saudi Arabia
     • United Arab Emirates
     • South Africa
     • Rest of Middle East & Africa
9. Competitive Landscape
10. Company Profiles
    • Berlin-Chemie
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • Pfizer
    • Sanofi
    • G1 Therapeutics, Inc.
    • Sun Pharma Advanced Research Company
    • Zenopharm
    • Arvinas
    • Sermonix Pharmaceuticals
    • Roche
    • AstraZeneca
    • Novartis
    • Zentalis Pharmaceuticals
    • Olema Pharmaceuticals
11. Conclusion and Future Outlook
12. Appendix
    • Research Methodology
    • About the Pharmanucleus

13. Disclaimer